Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.43)
# 1,164
Out of 4,531 analysts
588
Total ratings
46.3%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintained: Buy | $200 | $108.32 | +84.64% | 30 | Jul 17, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $46 | $22.80 | +101.75% | 8 | Jul 15, 2026 | |
| CELC Celcuity | Maintained: Buy | $175 | $88.38 | +98.01% | 10 | Jul 15, 2026 | |
| CADL Candel Therapeutics | Initiated Coverage: Buy | $22 | $10.18 | +116.11% | 1 | Jul 13, 2026 | |
| NRIX Nurix Therapeutics | Rated: Buy | $34 → $40 | $23.12 | +73.01% | 30 | Jul 10, 2026 | |
| PYXS Pyxis Oncology | Maintained: Buy | $8 | $2.36 | +238.98% | 6 | Jul 2, 2026 | |
| ZYME Zymeworks | Maintained: Buy | n/a | $24.19 | - | 32 | Jun 28, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $30 | $14.75 | +103.39% | 17 | Jun 23, 2026 | |
| INCY Incyte | Maintained: Buy | $123 | $117.25 | +4.90% | 39 | Jun 15, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $111 | $76.15 | +45.76% | 10 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.05 | +192.68% | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.49 | -10.91% | 34 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $2.60 | +323.08% | 25 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $8 | $6.47 | +23.74% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $27.76 | +65.71% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $55.92 | -15.95% | 54 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $16.26 | +133.70% | 4 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $18.09 | +121.12% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $7.00 | +142.86% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.12 | +324.53% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $3.82 | +96.34% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.05 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $4.42 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.44 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $31.16 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.37 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $0.9866 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $7.00 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.7425 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $1.12 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.58 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.39 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $68.26 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 | $4.10 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $267.47 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $59.59 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $54.39 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $21.71 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.000001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $10.84 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $3.20 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.26 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $247.53 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.27 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.56 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $40.54 | n/a | 2 | Apr 8, 2013 |
Insmed
Jul 17, 2026
Maintained: Buy
Price Target: $200
Current: $108.32
Upside: +84.64%
Syndax Pharmaceuticals
Jul 15, 2026
Maintained: Buy
Price Target: $46
Current: $22.80
Upside: +101.75%
Celcuity
Jul 15, 2026
Maintained: Buy
Price Target: $175
Current: $88.38
Upside: +98.01%
Candel Therapeutics
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $10.18
Upside: +116.11%
Nurix Therapeutics
Jul 10, 2026
Rated: Buy
Price Target: $34 → $40
Current: $23.12
Upside: +73.01%
Pyxis Oncology
Jul 2, 2026
Maintained: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
Zymeworks
Jun 28, 2026
Maintained: Buy
Price Target: n/a
Current: $24.19
Upside: -
Crescent Biopharma
Jun 23, 2026
Maintained: Buy
Price Target: $30
Current: $14.75
Upside: +103.39%
Incyte
Jun 15, 2026
Maintained: Buy
Price Target: $123
Current: $117.25
Upside: +4.90%
Disc Medicine
Jun 3, 2026
Maintained: Buy
Price Target: $111
Current: $76.15
Upside: +45.76%
Jun 1, 2026
Maintained: Buy
Price Target: $6
Current: $2.05
Upside: +192.68%
May 14, 2026
Maintained: Hold
Price Target: $4
Current: $4.49
Upside: -10.91%
May 13, 2026
Maintained: Buy
Price Target: $11
Current: $2.60
Upside: +323.08%
May 12, 2026
Rated: Buy
Price Target: $7 → $8
Current: $6.47
Upside: +23.74%
May 12, 2026
Maintained: Buy
Price Target: $48 → $46
Current: $27.76
Upside: +65.71%
May 6, 2026
Rated: Hold
Price Target: $47
Current: $55.92
Upside: -15.95%
Apr 28, 2026
Maintained: Buy
Price Target: $38
Current: $16.26
Upside: +133.70%
Apr 8, 2026
Maintained: Buy
Price Target: $40
Current: $18.09
Upside: +121.12%
Mar 18, 2026
Maintained: Buy
Price Target: $17
Current: $7.00
Upside: +142.86%
Mar 5, 2026
Reiterated: Buy
Price Target: $9
Current: $2.12
Upside: +324.53%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $3.82
Upside: +96.34%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.05
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $4.42
Upside: n/a
Mar 12, 2025
Maintained: Buy
Price Target: $4
Current: $1.44
Upside: n/a
Nov 15, 2024
Maintained: Buy
Price Target: $4
Current: $31.16
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $4
Current: $2.37
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $7 → $6
Current: $0.9866
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $7.00
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.7425
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $3 → $1
Current: $1.12
Upside: n/a
Mar 12, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.58
Upside: n/a
Mar 11, 2021
Maintained: Hold
Price Target: $6
Current: $2.39
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $18 → $21
Current: $68.26
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $160
Current: $4.10
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $267.47
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $59.59
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $54.39
Upside: n/a
Apr 27, 2018
Maintained: Hold
Price Target: $17 → $16
Current: $21.71
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.000001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $10.84
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $3.20
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $8.26
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $247.53
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $6.27
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.56
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $40.54
Upside: n/a